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Introduction
The number of invasive electrophysiology procedures in the
last 25 years has significantly increased worldwide and is ex-
pected to further increase in the future. The majority of these
procedures is guided by fluoroscopy and in spite of recent devel-
opments is still associated with moderate occupational radiation
exposure.
The percentage of female medical school students and gradu-
ates has significantly increased in the last 10 years currently
reaching close to 50% both in the European Union (EU) and
USA. According to a US survey conducted in 2006 by the
American College of Cardiology Women in Cardiology Council,
the percentage of female cardiologists has increased in the last
10 years to 18% but still remains low compared to other special-
ities in internal medicine.1 The percentage of female trainees in
cardiac electrophysiology is only 11%.1 Although 30% of the fe-
male cardiologists performed procedures with radiation risk
while pregnant, the survey suggested that occupational exposure
is a concern to both men and women. Female cardiologists made
more changes in their training and careers to reduce or avoid ra-
diation exposure because of concerns related to risk to a de-
veloping foetus. Concerns related to occupational radiation
exposure before and during pregnancy is one of the reasons for
continuing female underrepresentation in interventional cardi-
ology and electrophysiology. In another previous survey among
physicians dealing with pregnant patients, important overesti-
mation of the teratogenic risk associated with radiation expos-
ure during pregnancy has been reported.2 Electrophysiology
and training in electrophysiology may be associated with signifi-
cant occupational radiation exposure. A lack of accurate know-
ledge and misinformation regarding the risk of occupational
radiation exposure before conception and during pregnancy can
cause unfounded fear leading to anxiety and altered career and
family choices. Negligence and non-compliance with current
radioprotection practices may be on the other side hazardous
for the personnel of the electrophysiology laboratory and the
unborn child.
Recently, several guidelines have been issued by the
International Commission on Radiological Protection (ICRP) on
radiological protection in medicine and specifically in cardi-
ology.3,4 These guidelines have also addressed occupational ex-
posure during pregnancy and proposed new recommendations.
Several organizations in subspecialties translated the ICRP guide-
lines and issued similar recommendations.5–8 The EHRA has
issued in 2014 a practical guide on ways to reduce radiation dose
for patients and staff during electrophysiological procedures.9
The purpose of the current document as an adjunct to the EHRA
practical guide is to describe the current knowledge on the risks
and to inform about current international recommendations and
legislations on occupational exposure in the electrophysiology la-
boratory to personnel with childbearing potential and during
pregnancy.
Evidence review
Members of the Task Force were asked to perform a detailed litera-
ture review, weigh the strength of evidence for or against a particular
procedure, and include estimates of expected health outcomes
where data exist. In controversial areas, or with regard to issues with-
out evidence other than usual clinical practice, a consensus was
achieved by agreement of the expert panel after thorough
deliberations.
This document was prepared by the Task Force with representa-
tion from EHRA and HRS. The document was peer-reviewed by
official external reviewers representing EHRA and HRS.
Consensus statements are evidence based, and derived primarily
from published data. In contrast to guidelines, we have opted for an
easier and user-friendly system of ranking using ‘coloured hearts’ that
should allow physicians to easily assess current status of evidence and
consequent guidance (Table 1). This EHRA grading of consensus
statements does not have separate definitions of level of evidence.
This categorization used for consensus statements (used in consen-
sus documents) must not be considered as being directly similar to
that used for official society guideline recommendations, which apply
a classification (Class I–III) and level of evidence (A, B, and C) to rec-
ommendations used in official guidelines.
Thus, a green heart indicates a ‘should do this’ consensus state-
ment or indicated procedure, that is based on at least one random-
ized trial, or is supported by strong observational evidence that it is
beneficial and effective. A yellow heart indicates that general agree-
ment and/or scientific evidence favouring a ‘may do this’ statement or
the usefulness/efficacy of a procedure. A ‘yellow heart’ symbol may
be supported by randomized trials based on small number of subjects
or not widely applicable. Strategies for which there has been scientific
evidence that they are potentially harmful and should not be used
(‘do not do this’) are indicated by a red heart.
Finally, this is a consensus document that includes evidence and ex-
pert opinions from several countries. The approaches discussed may,
therefore, include regulations that do not have the approval of gov-
ernmental regulatory agencies in all countries.
Relationships with industry and other
conflicts
It is EHRA/ESC policy to sponsor position papers and guidelines
without commercial support, and all members volunteered their
time. Thus, all members of the writing group as well as reviewers
have disclosed any potential conflict of interest in detail, at the end of
this document.
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Basic concepts and nomenclature
in radioprotection
Definitions of radiation exposure
Radiation exposure can be expressed as ‘absorbed dose’ or
‘kerma’ that represents the energy of absorbed radiation by an
organ or tissue per unit of mass, typically measured in milli-gray
(mGy).10 In biology, the term ‘equivalent dose’ is used, which
takes into account the radiation weighting factor relevant for the
biological effect of the absorbed radiation. It is expressed in milli-
sievert (mSv). For X-rays, mGy and mSv are numerically equiva-
lent (Table 2). In medicine, it is important to estimate the potential
biological effect, i.e. radiological risk for an individual (patient or
personnel). However, such estimations are difficult. The equiva-
lent doses for all exposed organs and tissues are combined, taking
into account their respective radiosensitivities, to obtain a global
quantity called ‘effective dose’ (ED) (which is also expressed in
mSv). E.g. the higher biological radiosensitivity of breast tissue ex-
plains why women have a higher estimated ED for the same level
of exposure. For children, radiation risk is higher due to the sensi-
tivities of their tissues and the longer time-horizon for potential
deleterious effects. Moreover, several genetic, environmental and
dietary variables can affect the variability of risk observed to any
given level of radiation, although these are not taken into account
when estimating the radiation risk.
Calculating and reporting radiation
exposure for patients
The most accurate estimation of ED received by patients is to calcu-
late organ equivalent doses with Monte Carlo simulations, taking into
account patient parameters (like age and gender) and exposure and
geometrical parameters (like angles and other physical imaging values,
ideally separately for each of the imaging sequences). From these
organ dose values, a global ED is estimated. There are several com-
puter programs for such calculations.11 It is recommended to use
organ doses for research and scientific reports but the approach is
not suited for routine practice.
In routine practice, ED of the patient can most simply be
approximated with a conversion factor from exposure values that
are provided by the imaging equipment. All modern X-ray systems
have to report a standard quantity that is ‘kerma area product’
(KAP), also called ‘dose area product’ (DAP). Kerma area product/
....................................................................................................................................................................................................................
Table 2 Radiation quantities
Radiation quantity Most used unit Comment
Absorbed dose mGy A physical quantity reporting the energy of ionizing radiation absorbed per unit mass by mat-
ter or tissue
Equivalent dose mSv The absorbed dose in a tissue or organ multiplied by a weighting factor as an indication for
its potential biological impact.This factor is 1 for X-rays
Effective dose mSv The tissue-weighted sum of the equivalent doses in all specified tissues and organs of the
body. It allows rough estimation of global biological risk to a standard person (patient or
medical worker)
KAP or DAP Gycm2 Measured or calculated by the X-ray system: the integral of air kerma across the entire X-ray
beam emitted from the X-ray tube (allows a crude estimate of ED by conversion factors)
Cumulative air kerma mGy The air kerma accumulated at the patient entrance reference point. Measured or calculated
by the X-ray system, can be used as a rough estimate of the cumulative skin dose
Personal dose equivalent (Hp) mSv Measured by occupational dosimeters, allowing (within specific preconditions) estimations of
organ doses (e.g. hand or eye) and ED of workers
Adapted with permission from Heidbuchel et al., EP Europace 2014.9
DAP, dose area product; ED, effective dose; KAP, kerma area product.
.................................................................................................
Table 1 EHRA-grading of consensus statements






Scientific evidence that a procedure is
beneficial and effective. Requires at
least one randomized trial, or is
supported by strong observational
evidence and authors’ consensus
(as indicated by an asterisk*)
Recommended/
indicated
General agreement and/or scientific
evidence favour the usefulness/effi-
cacy of a procedure. May be sup-
ported by randomized trials based
on small number of subjects or not
widely applicable
May be used or
recommended
Scientific evidence or general agree-





* Statement is supported by strong observational evidence and authors’
consensus.
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Dose area product is typically expressed in Gycm2, mGycm2, or
mGym2. Dose area product values integrate many more imaging
factors than just fluoroscopy time. It also takes into account the de-
gree of collimation, pulse frequency (and hence, number of frames),
and dose per pulse. Fluoroscopy time should not be an acceptable
measure of radiation exposure. The most used factor to convert
DAP or KAP values into estimated ED for adults is 0.20, i.e. ED
(mSv) = 0.20DAP (Gycm2).12 Thus, a value of 10 Gycm2 (which
is 10 000 mGy.m2) for a cardiac procedure represents about 2 mSv
in ED to the adult standard patient. Although conversion factors
ideally require specific values for each catheterization laboratory
(based on Monte Carlo calculations), the calculated ED remains an
estimate with an intrinsic inaccuracy of ±50%. Moreover, compari-
sons of ED become even more inaccurate when there are signifi-
cant dissimilarities between the age and sex distributions of the
patients or populations being compared.13 Nevertheless, for sake
of applicability in daily care, EHRA in a previous document has rec-
ommended to routinely use the internationally accepted conver-
sion factor of 0.2 mSv/(Gycm2).9 For women and children, the
conversion factor is higher since they have a higher risk of cancer
development by radiation. For women, the relative risk is roughly
1.38 compared to men.9,14,15 Therefore, for an adult woman one
should use the conversion factor 0.28 (0.2 1.38). Some authors
have suggested specific conversion factors for children with pro-
posed values being 3.7 ± 0.2 in neonates, 1.9 ± 0.2 for a 1 year old,
and 1 ± 0.1, 0.6 ± 0.1 and 0.4 ± 0.1 for 5-, 10-, and 15-year-old boys
(and further multiplication by 1.38 in case of girls).16 Radiation ex-
posure estimated as ED (based on DAP values) is a pragmatic ap-
proach to roughly compare the relative radiation risks to patients.
It may be a more natural way for physicians to compare the biolo-
gical risks to patients than DAP values itself, and much more cor-
rect than fluoroscopy duration.
Another obligatory value reported by the imaging equipment is
‘cumulative air kerma’ at the patient entrance reference point. When
the field of irradiation is the same throughout the procedure, this
roughly represents the cumulative skin dose to the patient, which is
expressed in mGy or Gy.17 In the US reporting, the Cumulative Air
Kerma (in mGy or Gy) value of the electrophysiological procedures
is preferred as compared to the EU where the KAP/DAP values are
used.
Risks of radiation exposure for patients
and personnel
Biological effects of ionizing radiation can be classified as stochastic
(carcinogenic and genetic effects) and deterministic (also called tissue
reactions). The most widely accepted model for stochastic effects is
the ‘linear non threshold’ model, i.e. any small amount of radiation in-
volves an increase in cancer risk without any threshold, and the prob-
ability increases linearly with increasing radiation dose.13,14 This may
even hold for cataract,18 although this is usually considered as a de-
terministic effect. For deterministic effects (e.g. skin injuries, cataracts,
etc.), there is a threshold of dose (below this threshold, the effect is
not produced) and the severity increases with the dose. The thresh-
old for skin injuries is considered at 2–3 Gy, but for radiation induced
opacities in the eye lens, the ICRP has proposed 500 mGy as
threshold.13 ICRP provided a dose threshold of 500 mGy for non-
cancer effects of ionizing radiation to the heart.13
Responsible use of radiation
Appropriate imaging is crucial in performing complex EP procedures
effectively and safely. The risk of radiation exposure always needs to
be balanced vs. the benefits of the imaging itself, based on three prin-
ciples: justification (i.e. is the use of radiation appropriate), optimiza-
tion (i.e. reducing dose for the needed diagnostic information), and
physician responsibility for occupational dose limitation (i.e. through
training and quality control).9,19
Monitoring radiation exposure
An individual monitoring program of radiation exposure is intended
to provide information about the optimization of protection and to
demonstrate that the worker’s exposure has not exceeded any dose
limit or the level anticipated for the given activities. The ICRP recom-
mends the use of two personal dosimeters for occupational dosim-
etry in cardiac catheterization laboratories: one worn on the trunk of
the body inside the apron (usually at waist level) and the other worn
outside the apron at the level of the collar or left shoulder. At least
one dosimeter (the collar dosimeter) should always be used.3 4 Each
dosimeter has a pre-determined location to be worn. The dosimeter
under the apron provides an estimate of the dose to the organs of
the shielded region, including the reproductive organs. The dosim-
eter worn outside the apron supplies an estimate of the dose to the
organs of the head and neck, including the thyroid and the lens of the
eyes (if unshielded), but greatly overestimates the doses to organs of
the trunk. The advice of a medical physicist should be sought to inter-
pret monitoring results. The ED can be estimated from the dosimeter
values for Hw (under the apron at the waist, although this position is
not critical) and Hn (above the apron at the neck) from the equation:
ED = 0.5 Hwþ 0.025 Hn.3,4 Requirements and recommendations for
the number and placement of dosimeters vary from country to coun-
try. During pregnancy, the individual dosimeters should be evaluated
monthly and the workers should be provided with their monthly
dose record. For pregnant workers who have declared their preg-
nancy, conceptus dose can be estimated using the dosimeter worn
under the apron on the front of the torso between shoulder and
waist level.3 Sometimes, for the same purpose, an additional dosim-
eter is placed on the mother’s abdomen, again under her radiation
protective clothing. Regulatory requirements to declare pregnancy
differ among countries, with a few countries allowing a pregnancy to
be not declared. In an international survey of 380 members of the
Society for Cardiovascular Angiography and Interventions’ Women
in Innovations group 8% of the female responders did not declare
pregnancy to their institutions.6 In some cases, prohibition from fur-
ther working near radiation by declaration of pregnancy played a
role. Not declaring pregnancy should be discouraged as it may pre-
clude proper monitoring of radiation exposure during the pregnancy.
It could also have negative legal consequences for the employee in
case of liability issues. An employee may have the option to request
and wear an abdominal/waist badge regardless of whether a preg-
nancy declaration has been made. The foetus is most sensitive to
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radiation effects between 8 and 15 weeks of pregnancy. This period is
often before the pregnant worker announces her pregnancy to
supervisors or co-workers, and therefore she may wish to request a
foetal badge before actually declaring pregnancy. A worker who is
considering pregnancy may also request an abdominal/waist badge.
Reading from this badge can help to establish the likely conceptus
dose that would be received with a normal work schedule. Based on
the information adjustment of work schedule preconception or dur-
ing pregnancy may be planned.7
The irregular or incorrect use of personal dosimeters is still a
problem in many catheterization laboratories and leads to inaccurate
occupational exposure estimation. Examples are not wearing the
dosimeter during the procedures, leaving the dosimeter in the fluor-
oscopy room or on the apron being worn by other colleagues or
swapping the dosimeters by wearing the inside dosimeter on the out-
side of the apron. In addition to monitoring personal exposure,
dosimeter use helps to increase awareness about radiological protec-
tion.4 Compliance with radiation badge policies during pregnancy is
essential and should be enforced.
Magnitude of radiation exposure
in electrophysiology
Depending on the nature of the procedure, the radiation dose to the
patient and the operator will vary considerably, mainly being
influenced by the imaging time and the image quality needed to per-
form the procedure safely and efficiently. From historical data, typical
values for the patient vary from 3.2 mSv for a simple diagnostic elec-
trophysiological study to higher values in more complex ablation pro-
cedures, such as in atrial fibrillation, for which the reported median
dose was 16.6 mSv (Table 3).9,20 Cardiac resynchronization device
implantation is associated with the highest radiation exposure with
patient’s mean ED reaching 22 mSv per procedure.9 Estimating the
radiation dose to the physician in general is much more difficult due
to the many variables involved from energy source to physician.
There is an impact of the hardware (detector size, image quality set-
tings), procedure-specific factors (tube angulations, collimation, pa-
tient BMI), laboratory setup (use of protective lead lining, position of
operator), and operator factors (use of personal protection).21 As a
general rule of thumb, about 10–20% of photons entering the patient
are scattered. Adequate lead lining above and below the patient table
is capable of blocking upwards of 80% of this scatter.22 A rough
worst-case estimate of total physician dose in this setting would be
5% of total estimated patient dose.
There are very few and small studies reporting occupational ex-
posure dose measurements in the electrophysiology laboratory.
In the reported studies, the average operator dose was quantita-
tively related to the average patient dose, but there was much
greater variation in operator doses.21,23 In a previous comprehen-
sive summary of a small number of studies involving low number
of patients operator doses varied by two to three orders of mag-
nitude (100–1000 times) for the same type of procedures.
....................................................................................................................................................................................................................
Table 3 Typical patient’ and physician’s radiation doses in electrophysiology
Type of study Effective dose to patient in mSv
median and range per procedure9
Effective dose to operator in mSv mean
and mean range per procedurea 23
Diagnostic electrophysiological study 3.2 URb
1.3–23.9
Ablation procedure 15.2 2.7
1.6–59.6 0.24–9.6




Ventricular tachycardia 12.5 URb
3–>_45
VVI/DDD PM or ICD implant 4 4.8
1.4–17 0.29–17.4
CRT implant 22 URb
2.2–95
Coronary angiography 7 4.4
2.0–16 0.02–38
Percutaneous coronary intervention 15 4.9
7–57 0.17–31
aThe reported mean doses and mean dose ranges are mean estimates from a small number of studies including low number of procedures performed before 2008 and should
be interpreted with caution. Operator doses varied by two to three orders of magnitude for the same type of procedure.
bUnder-reported: occupational exposure is reported in an insufficient number of procedures to produce representative numbers for operator effective doses.
AT/AVNRT/AVRT, atrial tachycardia, atrioventricular nodal re-entry tachycardia, atrioventricular re-entry tachycardia; CRT, cardiac resynchronization therapy; ICD, implant-
able cardioverter-defibrillator; PM, pacemaker; UR under-reported.
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Modest operator dose reductions over time were observed for
ablation procedures due to technological improvements. The
right column in Table 3 summarizes the reported mean EDs and
mean ED ranges received by the operators per procedure before
2008 from this summary.23 In general, implantation of cardiac
resynchronization devices is associated with highest operator ex-
posure dose due the proximity of the operator to the radiation
source. In a more recent study at the operator’s hand, a mean of
1.2 mSv (up to 9. mSv) per procedure exposure was measured
with a ring dosimeter.24 Given the reported great variability in oc-
cupational exposure mean doses per procedure (from 0.2 mSv to
59 mSv) and the low number of small studies included, the num-
bers in Table 3 are indicative and should be interpreted with great
caution. It should be also noted that ED for the operator does not
reflect the doses to unprotected parts of the body (as the hands
and the eyes) and overestimates the dose to the areas under the
apron. The dosimeter under the apron also overestimates actual
dose to the embryo because radiation attenuation by the moth-
er’s tissue is not considered. In a simulation study a conversion
factor between the pregnant worker’s air kerma and foetus dose
was proposed.25 The authors of this study calculated a conversion
rate of 0.27, 0.23, and 0.17 between air kerma and foetus dose in
the first, second, and third trimester, respectively.
Personnel in the electrophysiology laboratory who are pos-
itioned in the control room are protected by both shielding and
distance from the X-ray beam. Exposure factors for the operators
are 1000 times higher than staff working in the control room. The
supporting staff working in the operating room (nurse, techni-
cians, and anaesthetist) was also reported to receive significantly
(in one study 20 times) less radiation than the primary and assist-
ant operators.20 All personnel working in the catheterization la-
boratory should be trained in radioprotection measures and
should were personal protection and dosimeters. A simple way to
avoid unnecessary exposure is to stay in distance from the radi-
ation source whenever possible.
A more recent study reported physicians’ dose during various ab-
lation procedures with the use of a radioprotection cabin.26 The dir-
ectly measured radiation level was reduced to normal background
levels inside the cabin protected areas. Median dose outside pro-
tected areas (cabin or lead) was 57–452 mSv per procedure. Use of a
radioprotection cabin is therefore able to eliminate radiation risk
completely or almost completely.
The increasing number of AF ablation procedures, together with
the fact that transcatheter AF ablation is currently a complex proced-
ure requiring greater fluoroscopy duration and radiation exposure
than other catheter ablation procedures, has incentivized operators to
develop workflows and adopt technologies aimed at reducing ED dur-
ing these procedures. Non-fluoroscopic three-dimensional navigation
and electroanatomical mapping (EAM) systems have been developed
to address this need. Most experience exists with the Ensite-NavX sys-
tem (St.Jude Medical, USA) and the CARTO system (Biosense
Webster, USA). Both systems have been shown to reduce ED signifi-
cantly during AF ablation.27–30 In addition, these systems have been
used in synergy with other cardiovascular imaging modalities to further
reduce ED. Three-dimensional rotational angiography (3DRA) and
intracardiac echocardiography (ICE) have been used to acquire
detailed 3D anatomical models that can be integrated in EAM systems
and allow entire procedure workflows with limited or even zero radi-
ation exposure.31–33 As opposed to 3DRA, ICE is not associated with
radiation exposure to the patient. Several other systems are under ac-
tive development or in the early stages of commercialization and will
undoubtedly also incorporate low- or zero fluoroscopy workflows.
Complementing these mapping systems are images from traditional
cardiovascular imaging modalities, acquired to assist ablation proced-
ures by providing the operator with a 3D anatomical model. These
imaging modalities may reduce total ED both to the patient and the op-
erator in spite of preprocedural additional radiation to the patient.34,35
Electrocardiogram (ECG)-gated acquisition has enabled significant ED
reductions for computed tomography scans (non-gated or prospect-
ively gated ± 4 mSv vs. retrospectively ECG-gated ± 15 mSv).36 Using
low-dose 3DRA protocols, computed tomography-like 3D recon-
structions can be obtained at an ED of 1.0–6.6 mSv.33,37 Magnetic res-
onance imaging and ICE-guided catheter ablation offer promise for
high-resolution catheter imaging with minimal or no radiation, as well
as providing opportunities for real-time dynamic imaging.38
Occupational exposure during catheter ablation procedures has
significantly decreased in the last 5–10 years with the use of modern
technologies. However, there are no data reported yet on the cur-
rent range of occupational exposure and on the magnitude of de-
crease in the electrophysiology laboratory.
Methods to reduce radiation
exposure in the electrophysiology
laboratory
Irrespective of the gender of the first hand operator, working in
the electrophysiology laboratory carries its professional risk of
radiation-induced diseases which is why working in these environ-
ments is regulated strictly. A number of equipment-based and
personal radiation protection measures are available and can lead
to a substantive reduction of the overall radiation exposure dur-
ing invasive EP procedures. Table 4 is a summary of these recom-
mendations adapted from the EHRA practical guide.9 Similar
recommendations were issued as the 10 pearls of radioprotection
in a poster format available at the International Atomic Energy
Agency (IAEA) website.39
Specific recommendations for female
operators during pregnancy
There a number of reports on pregnant patients undergoing low or
zero radiation ablation procedures,40–46 but dedicated reports on fe-
male physicians performing invasive procedures during their own
pregnancy are scarce. However, some recommendations are com-
mon sense and frequently applied. In general, radiation awareness, ap-
propriate use of monitoring and radioprotection measures should
minimize exposure to the operator to lowest possible level during
pregnancy. Device implantation procedures expose the operator to
much more scattered radiation than invasive EP studies and careful
positioning and optional shielding should be achieved during these
procedures.24,47 A two-piece wrap around lead skirt and vest should
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be used with a minimum of 0.5 mm lead equivalence in the front
(where the two sides overlap) and 0.25 mm lead equivalence in the
rear. Adding a second apron will have a minimal effect on the concep-
tus radiation dose (providing only an additional 4.75% attenu-
ation).7 The additional weight due to extra protection has to be
traded-off with the additional orthopaedic strain and fatigue for the
working mother, with possible exacerbation of musculoskeletal and
orthopaedic symptoms very frequent in interventional
electrophysiologists and invasive cardiologists even outside preg-
nancy and when aprons are not worn.48–50 A radiation protection
cabin may be used if available.26 Whenever possible, further radiation
reduction measures such as using 3D mapping systems or remote
navigation systems can be employed to reduce the overall exposure.
A decrease of the workload specifically for procedures with high radi-
ation exposure should be arranged if possible and achievable and
chosen by the pregnant operator.
....................................................................................................................................................................................................................
Table 4 Recommendations for reduction of fluoroscopy exposure during electrophysiological procedures
Measure Effect on reduction Comment
Equipment-based factors
Lower frame rate for fluoroscopy and cine
acquisition
Important reduction of overall (patient and
operator) exposure
As low as 2.5 frames per second may be sufficient
for fluoroscopy
Use under table lead shielding 7-10 fold reduction of operator dose May be difficult if cranial/caudal projections are
chosen
Use over table lead glass shielding 4-10 fold reduction of operator dose Easily achieved even in device procedures
Use collimation 2 fold reduction of patient (and operator)
exposure
Regularly adjust collimation of the image to the
region of interest
Minimise the use of steeply angulated
projections
Reduction of patient and operator exposure In LAO the operator exposure can be up 6 times
higher as in RAO projection
Keep the patient as far as possible from X-ray
tube
Reduction of patient exposure Adjust the height of the table
Place image detector as close to patient as
possible
Reduction of operator exposure Detector should be adjusted after changing table
height
Use intermittent short radiation (as opposed to
continuous) radiation
Reduction of patient and operator exposure Avoid or minimalize radiation when advancing cath-
eters from the groin or retracting catheters
Avoid cine acquisition by use of “store fluoro”
option
Reduction of patient and operator exposure Fluoroscopy yields lower resolution images com-
pared to cine acquisition, but for documentation
of site of ablation or pulmonary vein venography,
this cine resolution is usually not necessary.
Avoid magnification Reduction of patient and operator exposure If possible collimation is preferred
Keep maximal distance from X ray source and
patient as practically achievable
Radiation exposure is inversely proportional to
the square of the distance
Doubling distance from the patient reduces scatter
exposure by a factor of 4
Personal protection factors
Wear complete lead apron protection (includ-
ing thyroid shield)
90-95% dose reduction in operator exposure Two-piece wraparound apron provides extra pro-
tection to the low abdominal region and distrib-
utes the aprons weight
Avoid exposing your own hands Dose reduction to operator’s hands Place metal object on the skin to mark puncture
site on fluoroscopy
Additional personal lead aprons (head, leg and
arm shields, gloves)
Dose reduction to protected regions Necessary for specific situations eg. device
implantation
Wear lead glasses Dose reduction in operator eye exposure Protection to the eye lenses: radiation cataract
Radiation cabin Zero exposure to operator’s body If available
Special features for catheter ablation
procedures
Use of 3D mapping systems Reduction to near zero exposure is possible
once the mapping/ablation process is started
Very much depending on operator experience and
system accuracy
Remote navigation systems Near zero exposure to operator as he/she is
located in control room
If magnetic navigation or remote mechanical naviga-
tion systems are available
For further details see the EHRA practical guide on ‘practical ways to reduce radiation dose for patients and staff during device implantations and electrophysiological
procedures.9
LAO, left anterior oblique view; RAO, right anterior oblique view
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Importance of training and education on
appropriate radiation protection
measures during cardiology residency
Radiation protection and comprehensive training in the correct use
of all available protection measures should be part of the curriculum
of all trainees in specialized EP/device training programs irrespective
of their gender.9 Careful attention should be taken of the correct use
of the protection shielding and personal protection by adequate lead
apron as well as constant use of the radiation dosimeters at the cor-
rect position.8 The attitude towards recognition of the radiation ex-
posure for both patient and operator/staff needs to be governed by
the reasonably achievable (ALARA) principle at all times. Long term
radiation exposure as a key health concern for all electrophysiology
laboratory personnel needs to be recognized.51–53
Effect of radiation exposure on
spermatogenesis and fertility in
electrophysiologists
Occupational exposure to potentially hazardous factors including ra-
diation can impact both male and female reproductive health.
However, due to obvious ethical constraints, only a few experimental
data are available and the majority of the findings are based on either
animal models or epidemiological studies.
Most of the studies are focused on male reproductive perform-
ance as testicular tissue is highly sensitive to ionizing radiation. Early
studies conducted on healthy volunteers exposed to different doses
of radiation showed clear dose-related effects on sperm production,
in terms of both the magnitude and the duration of sperm count sup-
pression.54 Transient sperm count deterioration was observed be-
tween 105 and 330 days after exposure with dose greater than
0.15 Gy. However, no clear effect has been reported after exposure
to less than 0.08 Gy. Similarly, the histological samples from two avail-
able human studies revealed suppression of prime population of
spermatogonia (stem cell populations of the germ cells) to about
20% of control values by 0.2 Gy and less than 1% by 4 Gy occurring
between 100 and 250 days after exposure. Comparable results were
also observed in animal models. However, it is important to state
that sperm counts appear to be less sensitive to low doses and more
sensitive to high doses than type A spermatogonia (the differentiating
group from the stem cell populations of the germ cells).55 Based on
those studies, a temporal damage resulting in short-term reduction
of sperm counts can be expected after absorbing of radiation dose in
the range of 0.11–0.15 Gy, while 2–3 Gy may result in long-lasting or
permanent sterility.56 In the occupational exposure dose range, these
effects do not occur. A recent study in health workers occupationally
exposed to ionizing radiation reported worse semen quality than un-
exposed controls (as assessed by motility characteristics, viability,
and morphological abnormalities), with higher incidence of sperm
DNA fragmentation and hyper-methylated spermatozoa, suggesting
that occupational radiation exposure may have substantial detrimen-
tal effect on sperm functional, genetic and epigenetic integrity in
health workers.57 Based on these reports, an occupational exposure
limit of 15 mSv/year has been adopted in several countries, and if this
limit is not exceeded,15 testicular effects of radiation are unlikely. In
comparison, an earlier simulation study of ED values, eye lens, skin,
and gonadal doses in EP laboratory personnel has shown that a pro-
cedure requiring 40 min of fluoroscopy yields a maximum ED of 129
mSv and a maximum gonadal dose of 57 mSv to operators wearing
0.35 mm lead-equivalent apron.58 This study has shown that operator
ED values vary by a factor of 40 due to positioning during fluoroscopy
and by a factor of 11 due to radiation protection equipment.
Undercouch protective shields reduced gonadal doses up to 98%.58
Exposure to noxious factors can potentially alter the sex ratio at
birth. However, studies among populations exposed to different
types of radiation have yielded conflicting and inconclusive re-
sults.59–62
As there are no applicable direct measurement methods to esti-
mate the influence of radiation exposure on female reproductive
health, evidence for such interactions is more indirect and based
mainly on observatory studies in survivors of childhood cancer.
Potential effect of radiation on genetic material is currently not
known and there is concern that germ cells may carry mutations that
could lead to genetic disease in offspring. However, large studies re-
ported a similar range of major and minor congenital abnormalities
between the offspring of patients exposed to radiotherapy for child-
hood cancer and normal populations.63 Furthermore, there was no
increased prevalence of cancer in offspring of childhood cancer sur-
vivors in the absence of known cancer predisposition syndromes.
Radiation might induce alterations in the hypothalamic–pituitary
axis function influencing fertility and outcome of pregnancy.
However, in human no data are yet available on the presence and im-
portance of these effects.
Effect of radiation exposure on
the foetus
In most cases, the estimation of radiation doses derived from occupa-
tional exposures in electrophysiology laboratories to the conceptus
is made by a medical physicist or by a radiation protection expert,
using the readings of personal dosimeters worn over and under the
protective apron. As a conservative approach, the monthly dose
registered by the personal dosimeter worn under the lead apron
(usually positioned at waist level for pregnant workers) is assumed to
be the dose to the conceptus and should be in the range of a few mSv
per month if radiation protection tools are properly used.5,64 These
doses depend on the shielding used (protection devices and lead
apron), increase with the workload, and vary according to how close
the worker is to the patient during the clinical procedures.
Radiation dose for the conceptus may be reported in mSv (equiva-
lent dose) or in mGy (mean absorbed dose). Both quantities and
units are used in the literature and are equivalent for X-ray radiation.
Importance of gestational age
Prenatal low doses (as typically received by workers properly pro-
tected in EP laboratories) present no measurable increased risk of
prenatal death, malformation, or impairment of mental development
over the background incidence of these entities. There are radiation-
related risks throughout pregnancy, which are related to the stage of
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pregnancy and the foetal absorbed dose. ICRP states that radiation
risks are most significant during organogenesis and the early foetal
period, somewhat less in the second trimester, and least in the third
trimester. Throughout most of the pregnancy, the embryo/foetus is
assumed to be at about the same risk for potential carcinogenic ef-
fects of radiation as are children.65 See more details in the section on
risks at different dose ranges.
Pre-conception irradiation of either parent’s gonads has not been
shown to result in increased cancer or malformations in children.65 In
2001, the United Nations Scientific Committee on the Effects of
Atomic Radiation (UNSCEAR) reported to the General Assembly
that ‘radiation exposure has never been demonstrated to cause her-
editary effects in human populations’.66
Risks at different dose ranges
The dominant effect of a moderate irradiation during the pre-
implantation is early death of the conceptus. At doses under 100
mGy, such lethal effects will be very infrequent.67 In the occupational
dose range of less 1–5 mSv exposure to the mother, death of the
conceptus due to radiation is not described.
The risk of malformation is greatest during the period of major or-
ganogenesis with an estimated dose threshold of around 100 mGy.
The ICRP judges that risks of malformation after in-utero exposure to
dose well below 100 mGy are not expected.15
The risk of reducing the intelligence quotient (IQ) occurs after
high-dose irradiation in the most sensitive period (weeks 8–15 post-
conception). Any effects on IQ following in utero doses under 100
mGy and in the mother’s occupational exposure range (<5 mSv)
would be of no practical significance.15
Estimating the risk of cancer induction is the most important sub-
ject in foetal exposure. The ICRP recognizes that there are particular
uncertainties on the risk of radiation-induced solid cancers following
in utero exposure and considers that it is prudent to assume that life-
time cancer risk following in-utero exposure will be similar to that fol-
lowing radiation in early childhood, i.e. at most, about three times
that of the population as a whole.15 If we consider the life-time risk of
fatal and non-fatal cancer of any type (solid tumours and leukaemia),
according to Biological Effects of Ionizing Radiation (BEIR) VII (2006)
estimation for age = 0 (newborn) the life-time cancer risk is estimated
to be around 1 in 500 for 5 mSv in utero exposure, and 1 in 2500 for 1
mSv in utero exposure.14 Table 5 presents the probability of healthy
births as a function of the absorbed dose to the conceptus above
average annual natural background radiation globally estimated at 2.4
mSv.9 Table 6 shows the spontaneous pregnancy risks in the general
population. Table 7 depicts the calculated life-time cancer risk follow-
ing in utero exposure.
The risk of conceptus death, malformation or childhood cancer in
the occupational exposure range of the mother respecting the 1 and
5 mSv limits during pregnancy is negligible.
Review of current international
recommendations on
occupational radiation protection
of pregnant workers from medical
professional organizations
This topic is referred to as ‘protection of pregnant worker’, but the
focus is on the protection of unborn child,69 a term used to cover the
entire time period of development from conception to delivery. The
special protection for the unborn child is justified since the foetus is
not a patient, will not benefit from medical procedures, is more sensi-
tive to radiation, and has a whole life-time to develop radiation-
induced detrimental effects.68 After a worker has declared her preg-
nancy, the ICRP recommends that the additional dose to the unborn
child does not exceed about 1 mSv during the remainder of the preg-
nancy.3 The restriction of a dose of 1 mSv to the embryo/foetus of a
pregnant worker after declaration of pregnancy does not mean that
it is necessary for a pregnant woman to avoid work with radiation
completely, or that she must be prevented from entering or working
in designated radiation areas.3 The ICRP states that if a pregnant
woman wishes to continue her work in a fluoroscopy-guided proced-
ures laboratory, this should be allowed with the following conditions:
(i) she should do it on a voluntary basis and confirm that she has
....................................................................................................................................................................................................................
Table 5 Probability of a live birth without malformation or without childhood cancer as a function of radiation dose7






No malformations and no
childhood cancer (%)
0 96.00 99.93 95.93
0.5 95.999 99.926 95.928
1.0 95.998 99.921 95.992
5.0 95.99 99.89 95.88
10.0 95.98 99.84 95.83
Table 6 Spontaneous risks facing an embryo at
conception in the general population7
Risk of spontaneous abortion in known
pregnant women
1 in 7
Risk of major congenital malformations 1 in 33
Growth retardation 1 in 33
Risk of childhood leukaemia per year 1 in 25 000 per year
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understood the information provided on radiation risks; (ii) a specific
dosimeter should be used at the level of the abdomen to monitor the
dose to the foetus monthly, and the worker should be informed of
the dose values; (iii) a radiological protection program should exist in
the hospital or clinic, supervised by a medical physicist or equivalent
competent expert; (iv) the worker should know the practical meth-
ods to reduce her occupational dose, including the use of existing
radiological protection tools; (v) the worker should try to control
the workload in fluoroscopy guided procedures during her preg-
nancy; and (vi) the worker should know the risk of potential expos-
ures and how to reduce their probability. The <1 mSv dose
restriction is applied to the period of gestation after pregnancy is
declared, and exposures that may have incurred in early pregnancy
are not included in the total estimate of foetal dose. The IAEA Basic
Safety Standards present similar recommendations.70
In general terms, the same key principles of optimization of radio-
protection (time, distance, and shielding) suggested for the standard
worker71 may apply to the unborn child protection, but with some
more restrictive criteria (Table 8). As always, the best protection
comes from good radioprotection habits of the catheterization la-
boratory, routinely implementing a policy of dose optimization and
personal shielding.7 The 1 mSv limit (or 5 mSv limit in the USA) cannot
be regarded as a dose credit, but rather as the lower boundary of the
unacceptable exposure.72 The child exposure should always be opti-
mized towards the lowest possible levels, since the best dose for the
child is no dose, and the awareness of the mother is the best protec-
tion of the unborn child. When local regulations allow, as it happens in
the USA, the pregnant worker can continue to work on a voluntary
basis. As should be applicable to all radiation operators,8 the pregnant
worker should not only be cautious about radiation exposure but also
should be aware of protective and reduction measures.
Review of current legislations for
pregnant personnel in Europe and
in the USA
As a general rule the condition of pregnancy does not require remov-
ing the exposed professional from work, but careful review of work-
ing conditions to comply with current regulations is warranted.
At present, the EU member states national system for ionizing radi-
ation protection is based on the Directive 96/29/Euratom,73 which in
the case of pregnancy requires that as soon as a woman declares
pregnancy, the protection of the child to be born shall be comparable
with that provided for members of the public; that is, the equivalent
dose to the child to be born should be as low as reasonably achiev-
able and not exceed 1 mSv during at least the remainder of the preg-
nancy.73 The employer is responsible for training and providing
information on the radiation health risks (for the professional and the
child to be) and assuring that the working conditions of the pregnant
woman meet the safety criteria. On December 2013 a new revised
basic safety standards Directive was unanimously adopted by the EU
Council (Directive 2013/59/Euratom74). This new basic safety stand-
ards directive takes into account the recommendations from the
ICRP.13,15 The general instructions in regards to pregnant workers
are similar (i.e. once the woman has declared pregnancy, the em-
ployer must ensure that the foetus equivalent dose remains <_1 mSv).
The ICRP also requires for a radiation protection expert to give a
competent advice on the matters relating to the compliance with ap-
plicable legal requirements, in respect of employment conditions for
pregnant and breastfeeding workers.74 EU Member States will have
until February 2018 to translate this directive into national legislation
(Article 106—Directive 2013/59/Euratom74)
....................................................................................................................................................................................................................
Table 8 Protection of the pregnant worker (and unborn child)
Worker Pregnant worker
Allowed exposure <20 mSv/year <1 mSv in pregnancy (in EU) <5 mSv (in USA)
Awareness Cancer, cataract risks Child risks (including cancer)
Lead-equivalent apron 0.25 mm (>90% protection) 0.50 mm (>95% protection)
Dosimeter Above and/or under apron Waist level (under apron)
Dose reading Variable Monthly
....................................................................................................................................................................................................................
Table 7 Life-time risk of developing cancer following in utero exposure14,68
Probability of developing





Probability of developing cancer
if adding this extra-level of
risk (%LBR 1 %LAR)
No exposure 42 0 42
1 mSv exposure (age 0) 42 1 in 2500 42.04
5 mSv exposure (age 0) 42 1 in 500 42.20
Data refer to exposure at age 0 as the risk for in utero exposure. The calculations are based on references.14,68
LAR, lifetime attributable risk: the additional risk of premature incidence or mortality from a cancer attributable to radiation exposure; LBR, lifetime baseline risk: the chance of
having a cancer (incidence) and/or dying of cancer (mortality over the course of a life-time).
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There are other relevant European Directives, in regards to X-ray
exposure for pregnant healthcare workers:
• Directive 92/85/EEC75 on the introduction of measures to en-
courage improvements in the safety and health at work of preg-
nant workers and workers who have recently given birth or are
breastfeeding, which states that pregnant professionals cannot
perform activities involving risk of exposure to agents (including
ionising radiation) when, according to the conclusions of the risk
assessment, it can endanger her or the foetus’ safety or health. It
is the employer’s responsibility to assess the health risks, any
possible effect on the pregnancy, and to decide what measures
should be taken.
• Directive 2002/73/EC76 of the European Parliament and of the
Council on the implementation of the principle of equal treatment
for men and women as regards access to employment, vocational
training, promotion, and working conditions, which mandates
avoiding professional discrimination against women of childbearing
age.
In the USA, the National Council on Radiation Protection and
Measurements in Report No. 174 recommends limiting occupational
exposure of the foetus to a value ALARA, but not to exceed 5 mSv
(500 mrem) during the entire pregnancy and 0.5 mSv per month of
the pregnancy. If the gestational exposure is within 0.5 mSv of the
limit when the employee declares pregnancy, only an additional 0.5
mSv of exposure is recommended for the remainder of the preg-
nancy. It is advised that pregnant workers declare their pregnancy,
and that they wear an individual dedicated monitoring device worn
under the lead apron at the waist for the purposes of monitoring foe-
tal radiation exposure, if they choose to work in an exposed setting.77
These recommendations are implemented on a state-by-state basis.
In summary, legislations in both Europe and the USA seek to
protect women and foetus from damaging exposure while still
permitting reasonable risk for those who elect to work in a radi-
ation environment. However, despite the relatively homogeneous
directives, there is currently in fact great disparity in the approach
when a healthcare worker becomes pregnant and in the expect-
ations and rights of female interventional cardiologists. In the USA
through the Pregnancy Discrimination Act of 1978 (which
amended title VII of the 1964 Civil Rights Act), American em-
ployers are required to treat their female employees equally with
respect to ‘pregnancy, childbirth or related medical conditions’.
Legal precedent from the US Supreme Court was established in
1991 regarding the conflict between legislating foetal protection
and protecting maternal rights to non-discrimination, supporting
the female employee.6,78 As a consequence, the majority of US
hospitals allow interventional cardiologists to continue to work
with radiation exposure during pregnancy by federal and state
law. In contrast in Europe, the European directives were incorpo-
rated and interpreted in local law using own judgement in each
country. In general, the majority of European countries adopted a
stricter approach arguing that the 1 mSv dose limit cannot be
guaranteed.72 In many European hospitals, female interventional
cardiologists are not allowed to continue their work with radi-
ation exposure as operator by local law and employers’ imple-
mentation of local law.6 In conclusion, the different
radioprotection policies for pregnant workers reflect different
bioethical orientation of the law, which prioritizes the pregnant
Table 9 Consensus statements
Consensus statements
Measuring and monitoring radiation exposure
The DAP or KAP or cumulative air kerma (in mGy or
Gy) should be reported in all electrophysiological
procedures*
For occupational dosimetry, two personal dosimeters
should be used all the time correctly: one worn on the
trunk of the body inside the apron (at waist level), and
the other worn outside the apron at the level of the
collar or left shoulder. At least one dosimeter (the col-
lar dosimeter) should always be worn*
Pregnant occupationally exposed personnel should be
provided a dosimeter to estimate the conceptus radi-
ation dose. This dosimeter should be evaluated at min-
imum on a monthly frequency*
Reducing radiation exposure
The use of radiation should be governed by the as
ALARA principle*
Occupational and patient exposure should be further
decreased by training in radiation protection and the
correct use of available protection and dose reduction
measures*
Correct use of waist protection should be achieved with a
two-piece wrap-around apron with an anterior lead
equivalent thickness of 0.50 mm and provides >95%
protection*
Regulations for pregnant personnel
In the EU as soon as a woman declares pregnancy, the
protection of the child to be born shall be comparable
with that provided for members of the public; that is,
the equivalent dose to the child to be born should be
ALARA and not exceed 1 mSv during at least the re-
mainder of the pregnancy*
In the USA, occupational exposure of the foetus should
be limited to a value As ALARA, but not to exceed 5
mSv during the entire pregnancy and 0.5 mSv per
month of the pregnancy*
Pregnant medical workers may continue to work in a ra-
diation environment if they wish to provided that
there is reasonable assurance that the foetal exposure
dose can be kept below 1 mSv in the EU and 5 mSv in
the USA during the course of pregnancy and requiring
the employer to review the exposure conditions of
pregnant women carefully*
Declaration of pregnancy is encouraged as it allows proper
monitoring of radiation exposure during the pregnancy*
Occupational radiation protection measures should be
consistent with international standards and recom-
mendations in all electrophysiology laboratories and
must also comply with national and local regulations*
ALARA, low as reasonably achievable; KAP, kerma area product;
DAP, dose area product.
*Statement is supported by strong observational evidence and authors’
consensus.
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worker’s rights in an anti-discriminatory perspective in the US and
mostly the safety rights of the unborn child in the European legis-
lation. Additionally, despite the existence of the basic safety stand-
ards directives in the EU and USA, and the translation into
legislation, there is no clear guidance on how centres should im-
plement measures to ensure the woman’s and foetus’ protection
against ionizing radiation (number/type/location of dosimeters,
etc.).
Summary on safe use of radiation
for pregnant electrophysiology
personnel and individuals with
reproductive potentials
The expert consensus statements of this document are summarized
in Table 9. Radiation dose to the patient and the operator depends
on the nature of the electrophysiological procedure and for the pa-
tients varies between 3 and 17 mSv. Estimating the radiation dose to
the physician in general is much more difficult and may vary by two to
three orders of magnitude for the same type of procedures. The ED
to the operator is in the range of 0.2–60 mSv per procedure.
Complex ablations (especially in the past) and cardiac resynchroniza-
tion therapy implants are associated with higher doses. Although
health workers occupationally exposed to ionizing radiation have
recently been reported to have worse semen quality, radiation ex-
posure has never been demonstrated to cause hereditary effects in
human populations. Radiation risks are most significant during or-
ganogenesis and the early foetal period, somewhat less in the second
trimester, and least in the third trimester. Early death, malformation,
and mental retardation of the foetus do not occur in the occupational
exposure range. The probability of live birth without malformation
or childhood cancer at 1 mGy conceptus dose above the average an-
nual global natural background radiation of 2.4 mSv is 95.99% and at
5 mGy 95.88% as compared to 95.93% in the general population. In
the occupational exposure range working around radiation while
pregnant is typically safe, provided that proper protocols are adhered
to, including routine monitoring of occupational radiation dose to the
conceptus. The ICRP recommends that after a worker has declared
her pregnancy the additional dose to the unborn child does not ex-
ceed about 1 mSv during the remainder of the pregnancy.
Occupational radiation exposure during pregnancy is further regu-
lated in Europe by the directives of the EU and country specific and in
the USA by federal and state law. In EU member countries local law
interprets the European directives and employers are responsible for
implementing local law. Currently in many European hospitals con-
tinuation of work with radiation exposure is not allowed for pregnant
cardiologists. In contrast in the USA cardiologists may continue to
work with radiation exposure during pregnancy by both federal and
state law in the majority of US hospitals. This consensus document
supports the ICRP recommendation stating that pregnant medical
workers may work in a radiation environment provided that there is
reasonable assurance that the foetal dose can be kept below 1 mSv
(5 mSv in the USA) during the course of pregnancy and requiring the
employer to review the exposure conditions of pregnant women
carefully.65
Areas for future research
Female and male interventional electrophysiologists with a substan-
tially higher radiation exposure than diagnostic radiologists should be
focus of research. There are little data on fertility and the pregnancy
outcome of these specialists including spontaneous abortion, small
birth weight, birth defects, and childhood cancer in the offspring’s.
Data on occupational exposure dose ranges in the area of modern
electrophysiology are surprisingly scarce. It is mandatory to focus on
waist dosimetry, but it might be also useful to measure extra-waist
mother dosimetry in the pregnancy period, since head and neck ir-
radiation may impact pregnancy outcome.79 Currently, active per-
sonal dosimeters capable of real-time measurement of radiation dose
in the interventional cardiology field are being developed.80 The use
of these dosimeters during pregnancy with audible alarm above a
pre-set dose range would be ideal to avoid incidental overexposure.
It would be also important to collect dosimetry and reproductive
data on exposed men, since the gonadal irradiation in the vulnerabil-
ity window 1–10 weeks prior to conception may have impact on fer-
tility and child health.81 As evidence exists on the detrimental effects
of occupational radiation exposure on functional and genetic integrity
of germ cells a diagnostic sperm test might be added to occupational
health examinations. There is also lack of comprehensive data on re-
productive health of couples with integrated assessment of mother-
and-father (in the post-conceptional and, in case of fathers, pre-
conceptional 3-months period) to gain insight into the determinants
of fertility and offspring health.
Supplementary material
Supplementary material is available at Europace online.
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